Page last updated: 2024-09-05

symmetric dimethylarginine and bisoprolol

symmetric dimethylarginine has been researched along with bisoprolol in 1 studies

Compound Research Comparison

Studies
(symmetric dimethylarginine)
Trials
(symmetric dimethylarginine)
Recent Studies (post-2010)
(symmetric dimethylarginine)
Studies
(bisoprolol)
Trials
(bisoprolol)
Recent Studies (post-2010) (bisoprolol)
428273141,249392496

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A1

Trials

1 trial(s) available for symmetric dimethylarginine and bisoprolol

ArticleYear
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Japanese circulation journal, 2001, Volume: 65, Issue:9

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor

2001